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ABSTRACT When depolarized from typical resting membrane potentials (Vrest  90 mV), cardiac sodium (Na) currents are
more sensitive to local anesthetics than brain or skeletal muscle Na currents. When expressed in Xenopus oocytes, lidocaine
block of hH1 (human cardiac) Na current greatly exceeded that of 1 (rat skeletal muscle) at membrane potentials near Vrest,
whereas hyperpolarization to140 mV equalized block of the two isoforms. Because the isoform-specific tonic block roughly
parallels the drug-free voltage dependence of channel availability, isoform differences in the voltage dependence of fast
inactivation could underlie the differences in block. However, after a brief (50 ms) depolarizing pulse, recovery from lidocaine
block is similar for the two isoforms despite marked kinetic differences in drug-free recovery, suggesting that differences in
fast inactivation cannot entirely explain the isoform difference in lidocaine action. Given the strong coupling between fast
inactivation and other gating processes linked to depolarization (activation, slow inactivation), we considered the possibility
that isoform differences in lidocaine block are explained by differences in these other gating processes. In whole-cell
recordings from HEK-293 cells, the voltage dependence of hH1 current activation was 20 mV more negative than that of
1. Because activation and closed-state inactivation are positively coupled, these differences in activation were sufficient to
shift hH1 availability to more negative membrane potentials. A mutant channel with enhanced closed-state inactivation gating
(1-R1441C) exhibited increased lidocaine sensitivity, emphasizing the importance of closed-state inactivation in lidocaine
action. Moreover, when the depolarization was prolonged to 1 s, recovery from a “slow” inactivated state with intermediate
kinetics (IM) was fourfold longer in hH1 than in 1, and recovery from lidocaine block in hH1 was similarly delayed relative to
1. We propose that gating processes coupled to fast inactivation (activation and slow inactivation) are the key determinants
of isoform-specific local anesthetic action.
INTRODUCTION
Local anesthetics (LAs) block sodium currents more po-
tently during repetitive depolarizations (use-dependent
block) than during infrequent stimuli from rest (tonic block)
(Courtney, 1975). Modulated receptor models of LA action
(Hondeghem and Katzung, 1977; Hille, 1977) have attrib-
uted the complex sodium channel blocking actions of lido-
caine to distinct binding affinities for three conformational
states (closed, open, inactivated). Na currents through car-
diac Na channels are more sensitive to block by LAs than
are brain or skeletal muscle Na currents (Nuss et al., 1995b;
Wang et al., 1996b; Makielski et al., 1997), and this could
be interpreted as isoform-specific (but gating-independent)
structural differences in the lidocaine receptor. However,
recent studies challenge this notion and suggest that iso-
form-specific gating differences underlie apparent varia-
tions in LA sensitivity (Wright et al., 1997).
To examine the mechanism of isoform-specific LA ac-
tion, we measured tonic and use-dependent block by lido-
caine in heterologously expressed sodium channels from rat
skeletal muscle (1) and human heart (hH1). Our data
support the notion that isoform-specific lidocaine block
results from differences in gating rather than receptor dif-
ferences; however, we find that the kinetics of recovery
from lidocaine block are relatively insensitive to isoform
differences in fast inactivation gating, indicating that other
gating differences must critically influence isoform-specific
local anesthetic action. In contrast to the original formula-
tion of Hodgkin and Huxley (1952), activation, fast inacti-
vation, and slow inactivation gating are now known to be
linked functionally and structurally (Chahine et al., 1994;
Yang and Horn, 1995; Yang et al., 1996; Chen et al., 1996;
Aldrich et al., 1983; Armstrong and Bezanilla, 1977; Arm-
strong and Gilly, 1979). We find that differences in activa-
tion gating, by virtue of the tight coupling between activa-
tion and inactivation, are sufficient to explain isoform
differences in voltage-dependent availability and, second-
arily, lidocaine block. Moreover, differences in recovery
from block are augmented when depolarization is pro-
longed, suggesting that slower inactivation processes may
play a role in isoform-specific lidocaine action. Hence iso-
form-specific differences in lidocaine block are critically
linked to differences in activation and slow inactivation,
rather than differences in fast inactivation. Preliminary re-
ports of these results have appeared in abstract form (Nuss
et al., 1997, 1998).
MATERIALS AND METHODS
Channel expression and electrophysiology
Voltage-dependent steady-state availability of whole-cell Na current (INa)
was recorded from Xenopus oocytes, using a two-microelectrode voltage
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clamp (Warner Instruments Corp., Hamden, CT) 24–48 h after injection of
cRNAs coding for the  subunit of the rat skeletal muscle Na channel (1)
or the human heart Na channel (hH1). Adult female Xenopus laevis (Nasco,
Ft. Atkinson, WI) were anesthetized and oocytes were harvested as de-
scribed previously (Nuss et al., 1995b). In all cases (1 and hH1), the rat
brain 1 subunit was coinjected in five- to sixfold molar excess. The bath
solution was ND-96 (in mM: 96 NaCl, 2 KCl, 1 MgCl2, 1.8 CaCl2, 5
HEPES, pH 7.6 with NaOH). All recordings were obtained at room
temperature (20–22°C). Currents were sampled at 5–10 kHz and low-pass-
filtered at 1–2 kHz.
Recordings of INa for purposes of comparing 1 and hH1 activation
were performed under conditions of better voltage control, using small
HEK-293 cells (average cell capacitance 21 3 pF) stably transfected with
hH1 or 1. Na channel cDNA was subcloned into the HindIII-XbaI site of
the vector GFPIRS for bicistronic expression of the channel protein and
GFP reporter as previously described (Johns et al., 1997). Stable cells were
maintained in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with glucose (4.5 mg/L), fetal bovine serum (10%), penicillin/
streptomycin (1%), and geneticin (500 mg/L). For electrophysiological
recording, cells plated at low density were bathed in a modified Tyrode’s
solution composed of 135 mM NaCl, 4 mM KCl, 1 mM MgCl2, 10 mM
dextrose, 10 mM HEPES, 2 mM CaCl2 (pH 7.3 with NaOH). Pipettes were
filled with a solution containing cesium and fluoride to minimize back-
ground potassium and chloride currents (130 mM CsF, 10 mM CsCl, 10
mM HEPES, 10 mM EGTA, 1 mM MgCl2, pH 7.3 with KOH). To avoid
time-dependent shifts in the I-V curve due to intracellular dialysis (Wang
et al., 1996a), all experiments were performed within 5 min of patch
rupture. After fire polishing, pipettes had tip resistances of 4–6 M when
filled with the internal recording solution. Currents were filtered at 2 kHz,
using a 3-dB, four-pole low-pass Bessel filter with 1% overshoot
(Axopatch 200B; Axon Instruments). The sampling interval was 10 s
(100 data points/ms). Peak current amplitudes equaled4.8 0.6 nA, and
series resistance compensation was 80–90% during all experiments. As
such, the average uncompensated voltage error across the pipette was
calculated to be 3.6  0.4 mV.
All experiments were performed at room temperature. Voltage-clamp
protocols are described in the Results section or in the appropriate figure
legends. Pooled data are expressed as means  SE. Between-group dif-
ferences were compared using analysis of variance (Origin; MicroCal,
Northampton, MA). Exponential (Figs. 2 and 5) and Boltzmann (Figs. 1
and 4) functions were fitted to the data with a nonlinear least-squares
Marquardt-Levenberg algorithm (Origin).
FIGURE 1 Isoform differences in tonic block. (A) Whole-oocyte currents (INa) recorded at 20 mV are shown from an oocyte expressing hH1 channels
or 1 channels after 5-s prepulse periods to either 140 mV (solid lines) or 100 mV (dotted lines). Capacity artifacts are blanked, and currents were not
leak subtracted. Under drug-free conditions, the hH1 peak inward current magnitude was only slightly decreased by the more depolarized (100 mV)
prepulse. The same oocytes were then exposed to 300 M lidocaine (right) and subjected to the same voltage-clamp protocols. The 1 currents were
reduced to the same extent after 140 mV and 100 mV prepulses; however, lidocaine block of the hH1 current was significantly augmented by the more
depolarized (100 mV) prepulse. (B and C) Drug-free (B) and drug-exposed (C) steady-state availability data were measured from peak INa. All data are
from paired comparisons with drug-free controls in the same oocyte (1: 6 oocytes; hH1: 9 oocytes). Both drug-free and drug-exposed INa at each test
potential were normalized to the drug-free INa recorded at 140 mV. INa was measured at 20 mV after a 5-s prepulse period at the test potential (140
mV to 50 mV in 10-mV increments). Each prepulse period was preceded by a 15-s equilibration period at 100 mV. The solid lines are a least-squares
fit of a Boltzmann function (y  {1  exp((V  V1/2)/)}1) to the mean data. 1 control: V1/2  62.4 mV,   4.3 1 lido: V1/2  80.7,   6.2;
hH1 control: V1/2  82.5,   6.5 hH1 lido: V1/2  99.0,   6.8.
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RESULTS
Isoform differences in voltage-dependent
availability and tonic lidocaine block
We performed voltage-clamp experiments aimed at explic-
itly defining the isoform-specific differences in the voltage
dependence of channel availability and tonic block. Fig. 1 A
shows INa recorded at 20 mV after a prepulse to either
140 mV (solid line) or 100 mV (dotted line) in oocytes
expressing either hH1 or 1 channels. In drug-free condi-
tions (left), the depolarized prepulse (100 mV) caused
little (hH1) or no (1) reduction in INa compared to the
current measured from 140 mV. Fig. 1 B shows drug-free
availability as a function of prepulse membrane potential for
both isoforms. Fitting a Boltzmann function (solid lines) to
the mean data indicated that half of the 1 channels were
unavailable at 62 mV, while V1/2 for hH1 was 83 mV.
Consistent with previous work (Nuss et al., 1995a; Wang et
al., 1996a), we detect a 21-mV difference in the voltage
dependence of INa availability for the two isoforms.
With exposure to lidocaine (Fig. 1 A, right), there was a
small reduction in 1 INa that was identical after prepulses to
140 mV and100 mV. Furthermore, from a holding poten-
tial of 140 mV the lidocaine-induced reduction in hH1 INa
was similar to that of 1. In contrast, lidocaine markedly
reduced hH1 INa after a prepulse to100 mV. Examination of
voltage-dependent INa availability during exposure to lidocaine
(Fig. 1 C) confirmed that hH1 channels were far less available
than 1 channels after a prepulse to100 mV (hH1: 41 7%
versus1: 80 7%, p 0.002), while at more hyperpolarized
voltages (140 mV) such differences were reduced (hH1:
75  9% versus 1: 84  7%, p  0.52). These findings are
consistent with recent reports showing that isoform-specific
local anesthetic tonic block generally parallels the isoform-
specific difference in the voltage dependence of availability
(Wright et al., 1997, 1999).
Although the parallel shift in drug-free availability and
lidocaine action implicates depolarization-induced gating
processes in isoform-specific block, the mechanistic under-
pinnings of this process remain unclear. This complexity
was noted by Wright et al. (1999), who found that a simple
two-affinity model (Bean et al., 1983) employing high and
low-affinity binding to fast inactivated and rested states did
not reliably predict the lidocaine-induced steady-state avail-
ability shifts in 1/hH1 chimeras. In addition to fast inac-
tivation, a number of coupled gating processes importantly
contribute to the voltage dependence of channel availability,
including activation and slow inactivation. Thus we consid-
ered the role of these individual gating processes relative to
isoform-specific availability and lidocaine action.
Use-dependent block is relatively insensitive to
isoform differences in fast inactivation
Voltage-clamp studies of INa in native cells (Bean et al.,
1983) and with inactivation enzymatically (Yeh, 1978; Ca-
halan, 1978) or genetically removed (Bennett et al., 1995;
Balser et al., 1996b) suggest that lidocaine binds with high
affinity when channels inactivate. Use-dependent local an-
esthetic action has also been altered in Na channels with
more subtle gating lesions that alter fast inactivation (An et
al., 1996; Wang et al., 1997; Dumaine et al., 1996; Fan et
al., 1996). Because hH1 and 1 exhibit marked differences
in recovery from fast inactivation (Wang et al., 1996a; Nuss
et al., 1995a), we examined recovery after relatively brief
prepulses to discern the effect of these gating differences on
recovery from lidocaine block. A paired-pulse voltage
clamp protocol (Fig. 2, top) was used to measure the rate of
recovery of Na channel availability after a 50-ms depolar-
ization to 20 mV. Fractional recovery (peak INa in the
second pulse relative to the first) is plotted as a function of
the recovery period at 100 mV (Fig 2 A, left) and 120
mV (Fig. 2 B, left). To facilitate visual comparison of the
slow recovery components, the data are also shown for each
recovery value after it has been normalized to the maximum
fractional recovery within each experiment (Fig. 2, right
panels). The solid lines (Fig. 2, left panels) show two-
exponential fits to the unnormalized data (see Table 1 for
fitted parameters). Under drug-free conditions (Fig. 2, open
symbols), the rapid component of recovery, attributable to
fast inactivation, was significantly faster for 1 than for
hH1, consistent with previous observations in both Xenopus
oocytes (Nuss et al., 1995a) and mammalian cells (Wang et
al., 1996a). At 100 mV, recovery from fast inactivation
had a time constant of 1.07  0.13 ms in 1 versus 6.15 
0.91 msec in hH1 (Table 1, part B, p 0.05). Following the
predominant fast component, a small (low amplitude: Table
1, part A, A2 	 0.1) slow component of recovery, attribut-
able to one or more slow inactivated states (Nuss et al.,
1995a, 1996), was kinetically indistinguishable in the two
isoforms under these conditions (2: Table 1, part C).
Lidocaine induced a substantial slow component of re-
covery in both isoforms (Fig. 2, solid symbols). The ampli-
tude of the slow recovery component increased to a similar
degree in the two isoforms (0.65 in Table 1, part A, solid
symbols at t  20 ms in Fig. 2), and the time constants of
slow recovery differed slightly (at 100 mV, 2 was some-
what greater in hH1; Table 1, part C; see comment in
Discussion). Hence the overall time course of recovery in
lidocaine (Fig. 2, right panels) was similar for the two
isoforms, despite persistent differences in the kinetics of fast
inactivation among the remaining fraction of unblocked
channels. Notably, the amplitude of the fast recovery com-
ponent in 200 M lidocaine was still significant (1  A2 
0.35), suggesting that the lidocaine receptor(s) were not
saturated at this drug concentration.
Isoform differences in voltage-dependent
availability reflect differences in activation
The shift in voltage-dependent availability between hH1
and 1 is paralleled by a voltage-dependent shift in iso-
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form-specific block by lidocaine (Fig. 1) (Wright et al.,
1997). Although differences in inactivation gating may partly
underlie the isoform differences in voltage-dependent avail-
ability, because activation and inactivation gating are coupled,
channel availability is heavily influenced by the voltage de-
pendence of activation. Studies comparing hH1 and 1 gating
have shown a 15 mV-shift in the activation threshold for
hH1 relative to 1 (Nuss et al., 1995a; Wang et al., 1996a), a
difference approaching the shift in steady-state availability for
the two isoforms (21 mV in Fig. 1 B). We therefore exam-
ined whether isoform-specific differences in the voltage de-
pendence of activation could underlie the observed differences
in voltage-dependent availability and lidocaine block.
If inactivation gating is mechanistically linked to activa-
tion, the two processes may be positively coupled such that
closed-state inactivation becomes more likely as the Na
channel partly activates with mild depolarization, as pro-
posed by Kuo and Bean (1994):
Scheme A
Scheme A predicts a delay of activation from “distant”
nonconducting states (C1, C2) relative to the more rapid
increase in macroscopic current when channels occupy
more “proximal” closed states (C3, C4) (Cole and Moore,
1960). Because of positive coupling with inactivation, an
isoform difference in voltage-dependent availability at
“resting” membrane potentials (Vrest  90 mV) would
prevail if hH1 channels are further along their activation
sequence at Vrest (i.e., C3, C4), while 1 channels remain in
more distal closed states (i.e., C1, C2). To test this predic-
tion, we compared the rates of Na channel activation for
hH1 and 1 channels in HEK-293 cells.
FIGURE 2 The lidocaine-induced delay in recovery of availability after a brief depolarization—fractional recovery of availability during repolarization
at100 mV (A) or120 mV (B) after a brief (50 ms) depolarization (paired-pulse voltage-clamp protocol shown at top). Fractional recovery was measured
as the ratio of peak INa in the second depolarizing pulse relative to the first and is plotted as a function of the repolarization interval (left panels). Because
of isoform differences in steady-state availability, comparison of the slow recovery components was facilitated by normalizing each data point to the
maximum (1 s) recovery value (right panels). The solid lines (left panels) show least-squares fits of a two-exponential function, y  A1(1  exp(t/1))
 A2(1  exp(t/2)) to the mean data, and Table 1 provides a summary of the parameters determined from fits to the individual experiments. Recovery
for the two isoforms is shown in drug-free conditions (open symbols, 100 mV: 1 (n  5), hH1 (n  6); 120 mV: 1 (n  5), hH1 (n  5)) and with
200 M lidocaine (filled symbols,100 mV: 1 (n 6), hH1 (n 6);120 mV: 1 (n 6), hH1 (n 7)). At both membrane potentials lidocaine induced
a similar slow recovery component in 1 and hH1.
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Fig. 3 shows representative current records from individ-
ual cells expressing hH1 (Fig. 3 A) or 1 (Fig. 3 B) chan-
nels. For hH1, the rate of current activation is sensitive to
changes in membrane potential positive to 140 mV (Fig.
3 A, inset; 130 mV current is shifted relative to 140 mV
current) but saturates at membrane potentials positive to
100 mV (Fig. 3 A, inset; 100 mV and 90 mV currents
superimpose). In the context of Scheme A, at membrane
potentials positive to 100 mV, the hH1 channels occupy
closed states so near to the open state that any additional
movement along the activation sequence induces closed-
state inactivation due to positive coupling. In contrast, the
sensitivity of 1 channel activation is shifted to more pos-
itive membrane potentials. The rate of current activation is
insensitive until the membrane potential becomes positive
to 130 mV (Fig. 3 B, inset; 140 mV and 130 mV
currents superimpose) and does not saturate at 100 mV
(Fig. 3 B, inset; even 90 mV and 80 mV currents are
incrementally shifted). Summary data quantifying the de-
pendence of activation rate on prepulse potential are pro-
vided in Fig. 3 C. The difference between the time to 50%
activation (T50%) associated with the most negative (140
mV) prepulse and that of the test prepulse is plotted for each
isoform. In this way, 
T50% indicates the degree to which
the activation rate has increased with prepulse depolariza-
tion. Fig. 3 C indicates that the 1 
T50% data were shifted
positive to hH1 by 20 mV. If activation and inactivation
are positively coupled (e.g., Scheme A), these activation
differences alone are sufficient to explain the isoform shift
in voltage-dependent availability. Admittedly, a contribu-
tion from isoform differences in inactivation gating cannot
be entirely excluded.
Lidocaine block of an S4 mutant that alters
activation/inactivation coupling
Fig. 3 suggests that hH1 channels are further along the
activation pathway than 1 channels at the same holding
potential. If this is correct, then according to the coupled
gating scheme (Scheme A) proposed by Kuo and Bean
(1994), more channels should undergo closed-state inacti-
vation at a particular holding potential in hH1 compared to
1. If we assume that this coupling paradigm between
activation and closed-state inactivation is correct and lido-
caine binds with high affinity to inactivated channels, then
hH1 channels will exhibit greater lidocaine block at the
same holding potential, as shown in Fig. 1. With a view to
probing this scheme, the paradigm predicts lidocaine block
should be sensitive to the extent of coupling between acti-
vation and closed-state inactivation. We therefore examined
the lidocaine sensitivity of a 1 channel with a mutation in
the domain IV, S4 segment (R1441C) that alters activation/
inactivation coupling (Chahine et al., 1994). Interestingly,
this mutation disrupts coupling in a complex manner that
reduces open-state inactivation but enhances closed-state
inactivation (Ji et al., 1996). If lidocaine block is facilitated
by closed-state inactivation, the mutant channel should ex-
hibit enhanced drug sensitivity at holding potentials where
closed-state inactivation is increased.
Fig. 4 shows a paired comparison of the lidocaine-in-
duced shift in voltage-dependent availability for R1441C
and wild-type 1. Boltzmann fits to the mean availability
data are shown by the solid lines, and parameters derived
from fitting the individual experiments are provided in the
figure legend. The R1441C channel exhibited reduced
availability relative to wild type at 70 mV (R1441C:
0.84 0.01, 1: 0.99 0.03, p 0.01), a holding potential
negative to the channel opening threshold where channels
become unavailable by inactivating from closed states. We
did not detect a shift in V1/2 for the drug-free channels (1:
58.0  0.5 mV; R1441C: 57.6  1.5 mV), in contrast
to the analogous mutation in hSkM1 (R1448C) when ex-
pressed in tsA201 cells (Ji et al., 1996). Although the lack
of an effect on V1/2 may reflect species differences (rat
versus human) or the expression system (oocyte versus
mammalian cell), the mutation-induced reduction in avail-
TABLE 1 Parameters obtained from fitting the expression y  A1(1  exp(t/1))  A2(1  exp(t/2) to the experiments
1 hH1 1  lidocaine hH1  lidocaine
A. Slow recovery amplitude (A2/A1  A2)
100 mV 0.120  0.03 0.087  0.06 0.668  0.02 0.630  0.04
120 mV 0.124  0.02 0.064  0.04 0.668  0.02 0.652  0.06
B. Time constant (1, ms)
100 mV 1.07  0.13 *6.15  0.91 2.69  0.38 *13.06  2.84
120 mV 0.71  0.11 *3.21  0.26 2.12  0.29 *3.89  0.51
C. Time constant (2, ms)
100 mV (621  36) (623  173) 435  108 *626  56
120 mV (881  108) (1595  700) 206  22 314  79
Parts A, B, and C list the parameters obtained from fitting the expression y  A1(1  exp(t/1))  A2(1  exp(t/2)) to the individual experiments
(unnormalized) represented in the left panels of Fig. 2. In part A, the amplitude of the slow recovery component is given as a fractional percentage of the
total amplitude (A2/(A1  A2)). * indicates values derived from fitting the hH1 data that differ (p  0.05) from the corresponding value in 1. Because
of the small amplitude of the slow recovery component (A2) in drug-free conditions, the respective time constants (2) are shown in parentheses (part C).
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ability at membrane potentials below the channel opening
threshold supports an effect of R1441C on closed-state
inactivation, consistent with the human isoform (Ji et al.,
1996). In the absence of a shift in V1/2, the reduced avail-
ability at membrane potentials negative to V1/2 predicts that
the fitted slope factor should increase, as was found (1:
4.2  0.3; R1441C: 6.7  0.5 mV, p  0.012).
Lidocaine caused a reduction in voltage-dependent avail-
ability at membrane potentials below the opening threshold
FIGURE 3 Activation of 1 and hH1 Na channels. HEK-293 cells stably
expressing hH1 (A) or 1 (B) were held at 100 mV and subjected to 1-s
prepulses to voltages from 140 mV to 80 mV in 10-mV increments
(protocol, top). Currents were recorded upon depolarization to 20 mV.
The insets amplify a 100-s activation period for each isoform. (C) Plot of
the time to 50% current activation (T50%) after holding at a range of
depolarizing prepulse potentials relative to the same measurement at 140
mV. Summary data are shown for HEK-293 cells expressing hH1 (n  8)
and 1 (n  7). T50% is measured from time 0 (shown in A and B), at the
onset of the voltage step to20 mV, to the time at which the current attains
50% of its peak amplitude. * indicates membrane potentials where be-
tween-group differences were significant (p  0.05).
FIGURE 4 Voltage-dependent lidocaine block of 1-R1441C. Voltage-
dependent availability was measured using the voltage-clamp protocol
from Fig. 1 in oocytes expressing wild type 1 (n  3) (A) and R1441C
(n  3) (B). Open symbols represent control data, and filled symbols show
the results after paired exposure to lidocaine (300 M). Solid lines are fits
of the mean data to a Boltzmann function; parameters (mean SE) derived
from fitting data from individual oocytes were as follows: wild type: V1/2
58.0  0.5 mV,   4.2  0.3; wild type  300 M lidocaine: V1/2 
73.5  0.7 mV,   5.3  1.0; R1441C: V1/2  57.6  1.5 mV,  
6.7  0.5; R1441C  300 M lidocaine: V1/2  82.5  1.1 mV,  
9.3  1.2. Lidocaine induced a greater shift in V1/2 for R1441C than wild
type (see text).
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(70 to 100 mV) that was greater in R1441C than in
wild-type 1 (Fig. 4, bottom). Consistent with these results,
lidocaine induced a greater shift in the fitted V1/2 for
R1441C (24.1 0.1 mV) than for wild-type 1 (15.5
2.3 mV, p  0.016). Hence, lidocaine block was increased
by 1) isoform differences in coupling between activation
and closed-state inactivation (Fig. 3) or 2) a mutation that
alters coupling between activation and closed-state inacti-
vation (Fig. 4). While these observations suggest that lido-
caine block is sensitive to factors that modulate coupling
between activation and closed-state inactivation, alternative
mechanisms involving lidocaine binding directly to acti-
vated states are also possible (Vedantham and Cannon,
1999); they are considered below (Discussion).
Slow inactivation distinguishes isoform-specific
use-dependent block
Figs. 3 and 4 suggest that differences in coupling between
activation and closed-state inactivation underlie isoform
differences in the voltage dependence of lidocaine block
(Fig. 1). Nonetheless, Fig. 2 shows that the rate of recovery
from lidocaine block after a brief (50 ms) depolarization is
generally similar for hH1 and 1, an apparent inconsistency
given earlier evidence (Nuss et al., 1995b; Wang et al.,
1996b) that use-dependent lidocaine block differs in the two
isoforms. Notably, during sustained depolarizations (or
rapid pulse trains that do not allow full recovery from
inactivation), Na channels may enter stable (slow) inacti-
vated states that are distinct from fast inactivation (Adelman
and Palti, 1969; Chandler and Meves, 1970; Rudy, 1978).
We have shown that mutation of a tryptophan in the outer
pore of 1 (W402A, W402C) attenuates entry into an inacti-
vated state with intermediate recovery kinetics (denoted IM)
(Balser et al., 1996a; Kambouris et al., 1998a; Benitah et al.,
1999). At the same time, mutation of this tryptophan speeds
recovery from lidocaine block (Kambouris et al., 1998a). A
recent report found that classic slow inactivation (induced
by 60-s depolarizations, recovery time constants  1 s) is
less complete in hH1 than in the skeletal muscle isoform
hSkM1 (see comments in Richmond et al., 1998). However,
the kinetic features of IM are distinct from classic slow
inactivation: IM is induced by shorter depolarizations (1
s), and recovery from IM has time constants of 100–300 ms
in 1 (Kambouris et al., 1998a; Benitah et al., 1999).
Fig. 5 compares recovery from inactivation for 1 and
hH1 after a 1-s depolarization (in contrast to Fig. 2, where
only a 50-ms depolarization was used). The solid lines show
exponential fits to the mean data (see legend); parameters
obtained by fitting the individual experiments are provided
in Table 2. In addition to the isoform differences in recovery
from fast inactivation already noted with brief depolariza-
tions (Fig. 2), a slow recovery component was amplified by
the more lengthy depolarization that is consistent with IM. In
the absence of lidocaine (Fig. 5, open symbols), this slow
component was more pronounced in hH1 than in 1. While
the amplitude (A2) may have been slightly increased in hH1
compared to 1 (0.19  0.01 vs. 0.14  0.02, p  0.06),
the time constant of slow recovery (2) was more than
fourfold longer in hH1 (719  105 ms versus 145  16 ms,
p  0.001, left bars in Fig. 5 B). Upon exposure to lido-
caine, the amplitude of the slow component of recovery was
increased in both isoforms, and in contrast to Fig. 2 the
isoform difference in the rate of slow recovery persisted.
The time constant of the drug-induced slow recovery com-
ponent was significantly longer in hH1 than in 1 (581 
FIGURE 5 Time course of recovery of availability after a prolonged
depolarization. The paired-pulse voltage clamp protocol is shown (top).
Fractional recovery from inactivation was measured after a 1-s depolar-
ization in oocytes expressing either 1 (‚) or hH1 (E) channels using
control (E, ‚) or lidocaine-containing solutions (F, Œ). Although the
lidocaine concentration was 700 M for 1 and 300 M for hH1, recovery
of 1 was still considerably more rapid than recovery of hH1. The
exponential function y  A1(1  exp(t/1))  A2(1  exp(t/2)) was
fitted to the mean recovery data (solid lines), and parameters obtained by
fits to the individual experiments are shown in Table 2. Recovery was
assessed using a minimum repriming interval of 8 ms at 100 mV, so a
time constant for recovery from fast inactivation (1) was not estimated
precisely. The numbers of oocytes were as follows: 1, n  5; 1 
lidocaine, n 6; hH1, n 6; hH1 lidocaine, n 8. Elements of the data
were taken from previous work (Kambouris et al., 1998a; Nuss et al.,
1995b). (B) The time constants for recovery from inactivation (from Table
2) are plotted for drug-free conditions (left) and in lidocaine (right). In
either case, * indicates that the recovery time constant for hH1 was
signficantly longer that that of 1 (p  0.001).
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47 ms versus 298 11 ms, p 0.001, Fig. 5 B, right bars),
despite exposure of the 1 channel to more than twice the
drug concentration. For the hH1 channel, the rapid recovery
component was entirely eliminated (Fig. 5 A), while in 1
a small-amplitude (0.26) rapid component of recovery re-
mained. These findings suggest that differences in slow
inactivation gating influence isoform-specific lidocaine
block during periods of sustained depolarization.
DISCUSSION
Gating processes coupled to fast inactivation
influence isoform-specific lidocaine block
Isoform differences in Na current sensitivity to lidocaine
have been interpreted as intrinsic differences in the local
anesthetic receptor (Nuss et al., 1995b; Wang et al., 1996b;
Makielski et al., 1997). However, our results (Fig. 1) and
those of others (Wright et al., 1997) indicate that such
differences track voltage-dependent availability, implicat-
ing gating factors rather than receptor affinity in isoform-
specific block. Based on this finding alone, it is impossible
to conclude which of the gating processes that determine
voltage-dependent availability actually underlies the iso-
form difference in lidocaine block. A recent analysis utiliz-
ing 1/hH1 chimeras (Wright et al., 1999) suggested that
gating mechanisms other than fast inactivation may contrib-
ute to isoform-specific local anesthetic action. Because volt-
age-dependent availability reflects an interaction among
several “linked” gating processes (activation, fast inactiva-
tion, slow(er) inactivation), we considered the roles of each
of these processes in isoform-specific block. Our results
suggest that fast inactivation gating alone poorly explains
isoform-specific lidocaine block: after a brief depolarization
(50 ms), the two isoforms exhibit little difference in recov-
ery from lidocaine block, despite marked kinetic differences
in recovery from fast inactivation (Fig. 2).
Fig. 3 hints that isoform differences in voltage-dependent
availability may be linked to differences in activation gat-
ing. The rate of hH1 current activation is shifted more by
prepulse depolarization than is 1 (Fig. 3 C), suggesting the
hH1 channel resides in a more “activated” or “proximal”
closed state (Scheme A: C3 or C4) during prepulse depolar-
izations near Vrest. If activation and inactivation are posi-
tively coupled, the depolarized hH1 channel is more likely
to inactivate from a closed state. Could increased hH1
lidocaine sensitivity at modestly depolarized potentials
therefore result from enhanced closed-state inactivation? A
1 mutant with enhanced closed-state inactivation gating
kinetics (R1441C; Fig. 4) produced a greater lidocaine-
induced hyperpolarizing shift in voltage-dependent avail-
ability. Consistent with this finding, we have recently found
that a disease-linked mutation of the analogous S4 residue
in hH1 (R1623Q) similarly augments both closed-state in-
activation and the lidocaine-induced shift in voltage-depen-
dent availability (Kambouris et al., 1998b). Moreover, lido-
caine block was stabilized by the homologous cysteine
mutation in hSkM1 (Fan et al., 1996).
A model that considers slow inactivation in
lidocaine block
Our findings (Figs. 2 and 5) indicate that prolonging the
depolarization period from 50 ms to 1 s increases the
isoform difference in recovery from lidocaine block. Impor-
tantly, after the longer depolarization the time constant of
slow recovery in both the absence (Fig. 5 B, left) and
presence (Fig. 5 B, right) of lidocaine was prolonged in the
cardiac isoform. The recognition that lidocaine block may
be mechanistically linked to a slow inactivation gating
process (Kambouris et al., 1998a; Khodorov et al., 1976;
Balser et al., 1996c; Zilberter et al., 1991) offers a means to
explain this difference.
Fig. 6 proposes gated-state pathways for recovery of
availability after either a short (left) or long (right) depo-
larization when lidocaine is bound to the channel. During a
short depolarization, channels would primarily occupy the
IF state. Our findings are consistent with earlier reports
showing that recovery from IF is considerably delayed for
hH1 relative to 1 (Fig. 2 A, Table 1, part B) (Nuss et al.,
1995a; Wang et al., 1996a). However, if the rate constant
for lidocaine unbinding is slow relative to the rate of recov-
ery from IF, then the rate of drug unbinding will prevail over
the isoform difference in gating to determine the overall rate
of recovery of availability in lidocaine. Although the overall
time courses of recovery from block in the two isoforms
were similar (Fig. 2), the slow time constant in lidocaine
was somewhat longer for hH1 at 100 mV (Table 1, part
C). This difference could partly reflect an effect of fast
inactivation gating differences (Table 1, part B) on the slow
recovery time course. However, a low-amplitude slow in-
activation component (consistent with IM) was consistently
present in drug-free conditions even after the short prepulse
in both isoforms (Table 1, part A). The rather small ampli-
tude of this component in drug-free conditions limited our
ability to detect an isoform difference in 2 (reflecting IM
stability) after these short prepulses. Nonetheless, given that
a marked isoform difference in IM stability was established
by using longer prepulses (Fig. 5), the small isoform dif-
ference in lidocaine recovery after short prepulses may well
TABLE 2 Parameters obtained from fitting an exponential
function to the individual experiments in Fig. 5.
(A2/A1  A2) 2 (ms)
1 hH1 1 hH1
Control 0.144  0.02 0.194  0.01 145  16 *719  105
Lidocaine 0.695  0.04 1.0 298  29 *581  47
* indicates values derived from fitting the hH1 data that differ (p  0.001)
from the corresponding value in 1.
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reflect a limited degree of drug binding to the IM state, even
under these conditions.
After a longer depolarization (Fig. 5), a larger fraction of
channels occupy IM in drug-free conditions. While slightly
more hH1 than 1 channels may enter IM (Fig. 5 A), the
major difference between the isoforms lies in the time
constant of recovery from IM, which is more than fourfold
slower for hH1 (Fig. 5 B, left, Table 2). With lidocaine
exposure during a longer, 1-s prepulse, Fig. 6 predicts that
the rate of recovery from block will be influenced by the
rate of recovery from the drug-free IM state because this rate
is slow compared to drug unbinding or recovery from fast
inactivation. Hence the isoform difference in the time con-
stant for recovery from IM with lidocaine present recapitu-
lates those differences seen in drug-free conditions, as il-
lustrated by Fig. 5 B.
In Fig. 6, we propose that the slow inactivated state is
entered sequentially after fast inactivation, analogously to
the model utilized in a recent study of slow inactivation in
hH1 with varying external [Na] (Townsend and Horn,
1997). Admittedly, most evidence suggests that “classic”
slow inactivation (Rudy, 1978; Featherstone et al., 1996),
with time constants of recovery on the order of seconds (see
figure 7A of Featherstone et al.), competes with fast inac-
tivation. In this case a model with parallel (rather than
sequential) entry into the fast and slow inactivated states
would be preferable. However, the inactivated state consid-
ered here (IM) has more “intermediate” kinetics (hundreds
of milliseconds) compared to classic slow inactivation, and
removal of fast inactivation (by an IFM 3 QQQ mutation
in the III-IV linker) slows entry into IM (Balser et al.,
1996a), consistent with sequential coupling.
A recent study found that lidocaine did not slow the rate
at which a cysteine placed in the III-IV linker fast inacti-
vation “latch” recovered accessibility to covalent modifica-
tion, suggesting that slow recovery from lidocaine block
does not require fast inactivation gate “trapping” (Vedan-
tham and Cannon, 1999). It was postulated that “activated”
channels, rather than fast inactivated channels, may provide
a high-affinity lidocaine receptor during brief (20 ms) de-
polarizations. Because the S4 mutation (R1441C) that aug-
ments closed-state inactivation also has subtle effects on
activation gating, a model that includes activated-state lido-
caine block would presumably be consistent with the data
presented in Fig. 4. At present, a number of studies support
roles for either activated channels (Wang et al., 1987; Mc-
Donald et al., 1989; Yeh and Tanguy, 1985; Vedantham and
Cannon, 1999) or fast inactivated channels (Bennett et al.,
1995; Cahalan, 1978; Yeh, 1978; Bean et al., 1983; Balser
et al., 1996b) as high-affinity lidocaine receptors in various
experimental conditions. In the model we propose (Fig. 6),
high-affinity lidocaine binding to activated or open channels
(rather than IF) could suffice to explain the similar use-
dependent block noted in the two isoforms after brief (50
ms) depolarizations (Fig. 2). Nonetheless, it is difficult to
reconcile the isoform differences in lidocaine block that we
observe during long (1 s) depolarizations (Fig. 5) with
high-affinity binding to “activated” channels, because the
depolarized Na channel inactivates within only a few mill-
seconds. Hence our data are consistent with previous studies
(Khodorov et al., 1976; Zilberter et al., 1991; Balser et al.,
1996c; Kambouris et al., 1998a) supporting the general
hypothesis that slow inactivation, in addition to fast inacti-
vated or activated states, forms a high-affinity lidocaine
receptor. In summary, our findings suggest that isoform-
specific differences in lidocaine block are well explained by
isoform-specific differences in the gating processes coupled
to fast inactivation (activation and slow inactivation), rather
than intrinsic differences in fast inactivation or “structural”
differences in the drug receptors per se.
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